Global Drug Eluting Stents Market Overview
Stents are small narrow tubes which are inserted to keep the arteries open after a cardiac procedure known as angioplasty. A drug eluting stent is a coronary or peripheral stent which is incorporated in a diseased coronary or peripheral artery that slowly releases the drugs. Stents are generally placed within the coronary or peripheral artery by specialized cardiologists. These stents are the metal stents which are coated with a specific pharmacologic agent and the main role of this agent is to suppress restenosis.
A drug eluting stent stops the blockage to reoccur. There is a requirement of intense treatment with blood thinners to prevent the stents from closing. These stents usually refer to metal stents that have coating of pharmacological drugs which includes everolimus, paclitaxel and also the drugs which widens the narrowed blood vessel. The major role of drug eluting stent is that it broadens the constricted blood vessels and also prolongs the life of the patient.
Market Size and Forecast
The market is observing vibrant growth on account of increasing number of cardiovascular diseases (especially coronary heart disease), rising aging population, growing prevalence of obesity and diabetes. Rising adoption of minimally invasive endovascular surgeries and appropriate reimbursement policies along with increasing investment in the healthcare sector are some of the factors which are supporting the growth of the market. The drug eluting stents market is anticipated to record a CAGR of 5.6% over the forecast period i.e. 2019-2027. The market is segmented by application into peripheral artery disease and coronary artery disease, out of which, the coronary artery disease is expected to have the largest market share in the overall market owing to high prevalence of coronary heart diseases across the globe.
Get more information on this report: Download Sample PDF
Growth Drivers
Increasing Prevalence of Cardiovascular Diseases
The cardiovascular diseases are increasing worldwide and are one of the leading cause of death. Coronary heart diseases are increasing every year on account of artery blockage. According to World Health Organization (WHO), approximately 17.9 million people have died because of CVD’s in the year 2016, representing 31 percent of the total worldwide deaths. Out of these deaths, 85 percent are because of stroke and heart attacks. Rising cholesterol levels increase the chance of plaque formation in the arteries. The blockage of the arteries in the heart are removed by performing angioplasty in which drug eluting stents are widely used. This decreases the chance of reoccurrence of artery blockage in the future. The increasing prevalence of cardiovascular diseases is anticipated to augment the growth the market over the forecast period.
Rising Geriatric Population
Coronary heart diseases are directly associated with the age. Most of the coronary heart diseases takes place in individuals who are aged between 35 and 84. Coronary heart diseases often results in cardiac arrests. According to the report by National Institute of Health (NIH), the older population across the globe is expected to grow drastically. Worldwide, 8.5% of the population across the globe (617 million) are aged 65 and above. According to the latest report, this percentage is expected to increase to approximately 17% of total world population by the year 2050 (1.6 billion). This rise in the geriatric population is anticipated to support the growth of the global drug eluting stents market over the forecast period.
Restraints
Lack of Skilled Healthcare Professionals
With the growing incident rate of cardiac health problems, there is an increasing demand for healthcare professionals, especially the cardiologists. For instance, in India, there are 4,000 cardiologists, but the actual requirement is 88,000. This lack of cardiologists is expected to restrain the growth of the market over the forecast period.
Market Segmentation
Our-in depth analysis of the global drug eluting stents market includes the following segments:
By Coating
- Polymer Based Coating
- Polymer Free Coating
By Application
- Peripheral Artery Diseases
- Coronary Artery Disease
By End User
- Ambulatory Surgical Centers
- Cardiology Centers
- Hospitals
By Region
On the basis of regional analysis, the global drug eluting stents market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
North America is anticipated to lead the global drug eluting stents market on account of unhealthy lifestyle among people, suitable reimbursement policies, rising cardiac diseases and increasing obese and geriatric population across the region.
The Asia Pacific market of drugs eluting stents is expected to witness a significant growth on the back of rising pool of patients, rise in the disposable income, increase in patient awareness, enhancement in medical tourism and growing geriatric population. Enhancement in medical tourism, rising pool of patients and increase in disposable income are the prime factors which are anticipated to boost the market shares over the forecast period.
The global drug eluting stents market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis
Top Featured Companies Dominating The Market
- Abbott Laboratories, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Boston Scientific Corporation
- Cook Medical
- Cardinal Health
- Terumo Corporation
- Johnson & Johnson
- Medtronic, Inc.
- B. Braun Melsungen AG
- Stentys
- Biotronik
- Other Prominent Players
